Scott Hoffmann is a Senior Scientist at Roche since September 2025, following a tenure at AstraZeneca where Scott held the titles of Associate Director and Senior Scientist from October 2020 to October 2025. Prior experience includes serving as a PhD student at The University of Edinburgh from September 2015 to October 2020 and a summer intern at AstraZeneca in 2018, focusing on drug safety and metabolism within the Mass Spectrometry Imaging Team. Scott Hoffmann earned a Doctor of Philosophy in Biomedical Imaging/Cardiovascular Sciences and a Master of Science by Research in Biomedical Sciences from The University of Edinburgh, as well as a Bachelor of Science in Biology from the University of Dundee.
This person is not in the org chart
This person is not in any teams
This person is not in any offices